These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5064577)

  • 1. Chemical trapping of a reactive metabolite. The metabolism of the AZO-mustard 2'-carboxy-4-di-(2-chloroethyl)amino-2-methylazobenzene.
    Connors TA; Foster AB; Gilsenan AM; Jarman M; Tisdale MJ
    Biochem Pharmacol; 1972 May; 21(9):1309-16. PubMed ID: 5064577
    [No Abstract]   [Full Text] [Related]  

  • 2. Intestinal absorption of phenesterin (NSC 104469), an alkylating cholesterol ester.
    Feldman EB; Paul H; Cheron R
    Cancer Chemother Rep; 1972 Feb; 56(1):1-7. PubMed ID: 5030805
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytotoxic agents designed to be selective for liver cancer.
    Bukhari A; Connors TA; Gilsenan AM; Ross WC; Tisdale MJ; Warwick GP; Wilman DE
    J Natl Cancer Inst; 1973 Jan; 50(1):243-7. PubMed ID: 4692864
    [No Abstract]   [Full Text] [Related]  

  • 4. Distribution of new fluorene disulphonamido derivatives in rats with transplanted Walker carcinosarcoma.
    Malejka D
    Br J Cancer; 1966 Dec; 20(4):857-70. PubMed ID: 5964617
    [No Abstract]   [Full Text] [Related]  

  • 5. Sequential enzymic activation as a means of increasing therapeutic efficiency of nitrogen mustards.
    Dalton C; Hebborn P
    Biochem Pharmacol; 1965 Nov; 14(11):1567-76. PubMed ID: 5867511
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical pharmacology of a hepatoma-specific alkylating agent.
    Curt CA; Cannors TA; Murray-Lyon IM; Tattersall MH
    Biochem Pharmacol; 1977 Sep; 26(18):1715-8. PubMed ID: 197970
    [No Abstract]   [Full Text] [Related]  

  • 7. N-(2-chloroethyl)-N-(2-hydroxyethyl)arylamines. Possible intermediates to potential carcinolytic agents bearing dissimilar reactive functions.
    Foster AB; Jarman M; Ross WC; Tisdale MJ
    J Med Chem; 1972 Aug; 15(8):869-70. PubMed ID: 5044312
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism of a tartrazine analogue by intestinal bacteria.
    Ryan AJ; Welling PG; Roxon JJ
    Food Cosmet Toxicol; 1969 Jul; 7(4):297-9. PubMed ID: 4898704
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism of aniline mustard (N,N-di-(2-chloroethyl)aniline).
    Connors TA; Farmer PB; Foster AB; Gilsenan AM; Jarman M; Tisdale MJ
    Biochem Pharmacol; 1973 Aug; 22(16):1971-80. PubMed ID: 4726563
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolism of spirohydantoin mustard in the mouse. Isolation of an alkylating, mutagenic metabolite.
    Suling WJ; Struck RF; Woolley CW; Shannon WM
    Biochem Pharmacol; 1983 Feb; 32(3):523-7. PubMed ID: 6342622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the toxicity and antitumour activity of alkylating drugs by steroids.
    Shepherd R; Harrap KR
    Br J Cancer; 1982 Mar; 45(3):413-20. PubMed ID: 7073935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early stage in the metabolism of aminoazo dyes in the liver of rats.
    Du Plooy M; Dijkstra J
    Chem Biol Interact; 1972 Feb; 4(3):163-73. PubMed ID: 4621530
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of a nitrogen mustard on the incorporation of amino acids into the proteins of tumor slices.
    Nyhan WL; Lampert F
    Cancer Res; 1966 Jul; 26(7):1430-4. PubMed ID: 5911585
    [No Abstract]   [Full Text] [Related]  

  • 14. Concentration of [14C]actinomycin D in various tissues following intravenous injection.
    Ro TS; Busch H
    Biochim Biophys Acta; 1965 Oct; 108(2):317-8. PubMed ID: 5893631
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative effects of alkylating agents and other anti-tumour agents on the intracellular level of adenosine 3',5'-monophosphate in Walker carcinoma.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1975 Jul; 24(13-14):1271-6. PubMed ID: 167787
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypothesis concerning the mechanism of action of some new alkylating agents from synthetic estrogens.
    Niculescu-Duvăz I; Neacşu C; Dobre V; Feyns V
    Neoplasma; 1966; 13(6):583-9. PubMed ID: 5956360
    [No Abstract]   [Full Text] [Related]  

  • 17. Aryl-2-halogenoalkylamines. XXV. Derivatives of sulphanilamide designed for selective deposition in neoplastic tissue.
    Calvert N; Connors TA; Ross WC
    Eur J Cancer (1965); 1968 Dec; 4(6):627-35. PubMed ID: 5717959
    [No Abstract]   [Full Text] [Related]  

  • 18. Antitumor and toxicologic effects of p-carboxycarbanilic acid, N-(p-(bis(2-chloroethyl)amino)phenyl) ester (NSC-130998; IC 140).
    Hebborn P; Simpson CL; Mihich E
    Cancer Chemother Rep; 1970 Feb; 54(1):23-30. PubMed ID: 5538162
    [No Abstract]   [Full Text] [Related]  

  • 19. The interaction of bifunctional alkylating agents with the DNA of tumour cells.
    Harrap KR; Gascoigne EW
    Eur J Cancer (1965); 1976 Jan; 12(1):53-9. PubMed ID: 1269527
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoradiographic evaluation of the distribution of N,N'-bis(thiazole)-2,7-fluorene-disulphonamide-35S in organs of rats.
    Kasprzak K; Malejka D; Gabryel P
    Nature; 1965 Jun; 206(990):1266-7. PubMed ID: 5879796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.